Related Experiment Videos
New PCR-based method for the Sp1 site polymorphism in the COL1A1 gene
A Vinkanharju1, T Melkko, J Risteli
1Department of Clinical Chemistry, University of Oulu, Finland.
Clinical Chemistry and Laboratory Medicine
|August 28, 2001
Summary
Researchers developed a new method to detect a COL1A1 gene polymorphism linked to osteoporosis risk. This simpler technique uses PCR and a restriction enzyme, improving upon older methods for genetic screening.
Area of Science:
- Genetics
- Molecular Biology
- Bone Metabolism
Background:
- Polymorphism in the Sp1 binding site of the COL1A1 gene is associated with osteoporosis risk.
- Previous detection methods using mismatch oligonucleotide primers were complex and difficult to implement.
Purpose of the Study:
- To develop a simpler and more efficient method for detecting the COL1A1 gene polymorphism.
- To analyze the frequencies of this polymorphism in a northern Finnish population.
Main Methods:
- Polymerase Chain Reaction (PCR) amplification of a 598-bp sequence from the first intron of the COL1A1 gene.
- Digestion of the amplified sequence with the restriction enzyme Van 91 I.
- Genotyping of 173 individuals from two convenience samples in northern Finland.
Main Results:
- The study successfully developed a restriction enzyme-based method for COL1A1 polymorphism detection.
- The G allele frequency was 0.864 and the T allele frequency was 0.136 in the studied population.
- Heterozygosity for this polymorphism was 27.2% in the northern Finnish sample.
Conclusions:
- The new PCR and restriction enzyme method provides a more accessible approach for studying COL1A1 gene polymorphism.
- The observed allele frequencies in northern Finland are within the lower range reported for European populations.
- This genetic marker remains relevant for osteoporosis risk assessment.